Welcure Drugs & Pharmaceuticals Ltd Share Price (524661)
as on
| Source : BSE
Welcure Drugs & Pharmaceuticals Ltd Stock Performance
as on August 26, 2025 at 4:01 pm IST
- ₹10.77₹10.77
52 Week's Low
52 Week's High
₹6.4₹15.89
40.58%
Downside
47.54%
Upside
| Market Stats | |
| Previous Close | ₹11.33 |
| Open | ₹10.77 |
| Volume | 4.76L |
| Upper Circuit | ₹11.89 |
| Lower Circuit | ₹10.77 |
| Day's Low | ₹10.77 |
| Day's High | ₹10.77 |
| 52 Week Low | ₹6.4 |
| 52 Week High | ₹15.89 |
| Returns % | |
| 1 Month Return | + 12.42 % |
| 3 Month Return | -5.19 % |
| 1 Year Return | + 46.93 % |
| 3 Year Return | + 36.5 % |
| 5 Year Return | + 438.5 % |
Welcure Drugs & Pharmaceuticals Ltd Stock Fundamentals & Key Indicators
Check Welcure Drugs & Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹121.18 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.52
P/B Ratio
3.76
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-6952.94
EPS (TTM)
0Sector
Castings, Forgings & Fastners
Book Value
5.64
Technical Analysis
Bearish
View Technical Analysis
Welcure Drugs & Pharmaceuticals Ltd Stock's Interest Amongst Investors
Welcure Drugs & Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Welcure Drugs & Pharmaceuticals Ltd, including revenue, profit, loss and more.
Welcure Drugs & Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Welcure Drugs & Pharmaceuticals Ltd.
Welcure Drugs & Pharmaceuticals Ltd Earnings Results
Welcure Drugs & Pharmaceuticals Ltd’s net profit jumped 6952.94% since last year same period to ₹23.30Cr in the Q1 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated 817.32% jump in its net profits since last 3-months.
Read More about Earnings Results
Welcure Drugs & Pharmaceuticals Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Welcure Drugs & Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 0% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 100% | 0.00 | |
| Others | 0% | 0.00 |
Welcure Drugs & Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Welcure Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 121.18 | 87.7% | 0.00 | NA | NA | |
| BUY | 8,581.44 | -2.34% | 0.55 | 267 | 1,408 | |
| NA | 1,123.52 | 12.58% | 0.62 | 55 | 931 | |
| NA | 86.32 | 3.06% | 0.00 | 6 | 201 | |
| NA | 377.16 | 961.59% | 0.00 | 5 | 120 |
Insights on Welcure Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, Welcure Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.9% return, outperforming this stock by 97.4%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 100.00% of holdings in Jun 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, Welcure Drugs stock has moved down by -12.7%
About Welcure Drugs & Pharmaceuticals Ltd
Apart from this, additional products like Stevioside, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF and XDRYL, were introduced in the year 2000–01. The company also entered into a collaboration agreement with Advanced Medical Care Inc, New Jersey, to set up joint venture facilities at their existing plant. In 2013, Welcure changed its marketing policy from sale through wholesale distributors to doorway sales, reaching every corner of the country through sales personnel and stockists. As of 2020, Welcure holds ISO 9002 certification with double accreditation from ABS Quality Evaluation Inc and Registrar of Accreditation Board of USA.
Revenue: ₹299.91Cr as on June 2025 (Q1 FY26)
Net Profit: ₹23.30Cr as on June 2025 (Q1 FY26)
| Organisation | Welcure Drugs & Pharmaceuticals Ltd |
| Headquarters | Delhi |
| Industry | Castings, Forgings & Fastners |
| E-voting on shares | Click here to vote |
FAQs
What is Welcure Drugs & Pharmaceuticals Ltd share price today?
Welcure Drugs & Pharmaceuticals Ltd share price today stands at ₹10.77, Open: ₹10.77, Previous Close: ₹11.33, High: ₹10.77, Low: ₹10.77, 52 Week High: ₹15.89, 52 Week Low: ₹6.4 as on .
How to buy Welcure Drugs & Pharmaceuticals Ltd shares ?
To buy Welcure Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 524661 or Welcure Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Welcure Drugs & Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Welcure Drugs & Pharmaceuticals Ltd?
Today's traded volume of Welcure Drugs & Pharmaceuticals Ltd is 4.76L. Which means that 4.76L shares of Welcure Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Welcure Drugs & Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Welcure Drugs & Pharmaceuticals Ltd is ₹121.18 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Welcure Drugs & Pharmaceuticals Ltd?
Welcure Drugs & Pharmaceuticals Ltd’s 52 week high is ₹15.89 and 52 week low is ₹6.4. The current share price of Welcure Drugs & Pharmaceuticals Ltd is ₹10.77, which is -32.22% down from its 52 week high and 68.28% up from its 52 week low.